<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prognosis of adult Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) has improved in western countries since the introduction of high-dose <z:chebi fb="0" ids="44185">methotrexate</z:chebi> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-MTX)-containing chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>Here we analyzed nine consecutive Japanese patients diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> at our institution </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> except for the three elderly (&gt; 70 years) patients were treated with a regimen including 13 g/m(2) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-MTX in total, divided into 3 cycles </plain></SENT>
<SENT sid="3" pm="."><plain>The median follow-up period was 56 months (range 38-118) </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the nine patients achieved complete remission and have not shown any disease progression, including the three elderly patients who received reduced doses or alternative treatments </plain></SENT>
<SENT sid="5" pm="."><plain>These observations suggest that chemotherapy including 13 g/m(2) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>-MTX in total is tolerable and effective in Japanese adult <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> patients aged &lt; 70 and that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> is curable even if developed in those who are &gt; 70 years </plain></SENT>
</text></document>